About the Company:
Walpar Nutritions Ltd is a manufacturing Company with wide range of Nutraceutical, Ayurvedic, Cosmeceuticals, Wellness and Food supplement products.
Company develops, manufactures and commercializes HERBO-NUTRACEUTICAL products including sales, marketing, quality assurance, distribution, compliance and regulatory aspects under Nutraceuticals.
WALPAR has developed more than 100 formulations and 1000 brands for third party for domestic market under different segments like Orthopaedics, Gynaecology, Paediatrics, Cardiac, Diabetic, Dermatology, Pain Management, Antibiotics, Neuro, Critical Care, Gastro-Intestinal and Sports nutrition.
WALPAR manufactures innovative products comprising of Tablets, Capsules, Liquid Orals, Ointments, Creams, Lotions, Gels and Sachet, powders and effervescent tablets.
Company is holding WHO, HACCP, HALAL, Kosher and ISO 9001:2015 certificate issued by Independent agencies and have also applied for patents of our three products.
Company is also engaged in trading of raw material used in manufacturing Nutraceutical products.
company has co-founded M/s Walpar Wellness Private Limited (herein after referred as Subsidiary) on January 6, 2021 and company is holding 60% Equity Stake in the subsidiary company.
Subsidiary company was co-founded to meet the export requirement for tablet, capsules, oral liquids and sachets and other special dosage forms which will be having installed capacity of approx. 30 to 45 lakhs tablets per day and approx. 2.5 lakhs capsules per day.
Company’s Manufacturing Facilities:
Company’s manufacturing unit is located at 4-9, and 21 at Shyam Estate, Santej, Ta: Kalol, Gandhinagar.
At present company has installed capacity of manufacturing of approx. 30 Lakhs tablets per month, 12.50 Lakhs capsules per month, 1.50 Lakhs oral liquids of (ranging from 15 ML to 200 ML) per month, and 2.00 Lakhs Sachets of (ranging from 1 gm to 10 gms) per month.
Setting up of New plant facility:
On February 5, 2021, Company’s Subsidiary company Walpar Wellness Private Ltd had already acquired land of Rs. 60.00 Lakhs situated at Block no. 377and 378 (sub plot no. 2/A) admeasuring area of 1158 Square meter at Khatraj village of Gandhinagar District in State of Gujarat for construction and setting up of plant facility.
Company’s Product range:
Company is into developing, manufacturing and marketing a broad range of healthcare products of Nutraceutical, Cosmeceutical and Ayurveda. We are primarily known for our premium range of Nutraceutical, Ayurveda and Cosmeceutical products.
Company has a product basket of more than 70 products and have a diverse oral sprays and effervescent product range and formulations from simple oil products to complex paste, powders ointments, creams and other formulations.
Company also deals in oil encapsulation and have expertise in capsule as well as tablet manufacturing and have the ability to supply products in various forms such as tablets, capsules, Gel, liquids, ointments, powder, pastes, etc. in different forms of packing.
In India, Company’s customers are located in the state/territory of Maharastra, Bihar, West Bengal, Jharkhand, Uttar Pradesh, Madhya Pradesh, Chattisgarh, Andhar Pradesh, Assam etc.
Company has also exported products in Srilanka, Bangladesh and Nepal through third party merchant exports.
Company has plans to Expand global footprint.
company has plans to explore franchising opportunities in manufacturing & distribution for increasing the brand’s footprint across Asia & the Middle East, EUROPE, USA going forward.
- Mr. Kalpesh Pravinchandra Ladhawala (Designation: Chairman cum Managing Director)
- Mr. Tanmaykumar Ashwinbhai Shah (Designation: Whole-Time Director)
Objectives of the Issue:
- Investment in Subsidiary.
- To Meet Incremental Working Capital Requirements.
- General Corporate Purpose.
- To meet Public Issue Expenses.
Financials of the Company: (in Lakhs)
|(in Lakhs)||FY 18||FY 19||FY 20||31st Dec 20|
Valuation of Peer Group Companies:
|Company Name||Face Value||EPS||PE Ratio||RoNW||NAV|
|Walpar Nutritions Ltd||10||0.41||135.44||6.53%||6.22|
|Earum Pharmaceuticals Ltd||10||2.94||25.48||12.59%||23.37|
|Valencia Nutrition Ltd||10||-9.48||-2||-89.69%||8.66|
|Issue Opens on||30th June 2021|
|Issue Closes on:||5th July 2021|
|Issue Size||Rs.6.6 cr|
|Market Cap||Rs.24.9 cr|
|Listing at||BSE SME|
|Equity Shares Offered (Fresh)||12,00,000|
|Equity Shares Prior to the Issue||33,41,220|
|Equity Shares after the issue||45,41,220|
Also Read : List of Upcoming IPO’s in India.
IPO Valuation Parameters:
|Earnings Per Share (EPS)||Price To Earnings ratio (PE)||Return on Net Worth (RoNW)||Net Asset Value (NAV)|
|Company Contact Info:|
|Walpar Nutritions Ltd
2nd Floor, L5: 377 PLOT:5,
Opp. Sabarmati, Village: Khatraj, Taluka kalol,
Telephone No.: +91 2764-662626;
Web site: www.walparnutritions.com
|IPO Registrar Info:|
|SKYLINE FINANCIAL SERVICES PRIVATE LIMITED
Address: D-153A, 1st Floor,
Okhla Industrial Area Phase-I, New Delhi – 110020, India.
Tel. Number: +91 -11-40450193-97
Email Id: firstname.lastname@example.org
|Lead Manager to the Issue:|
|BEELINE BROKING LIMITED
Address: 807, Phoenix Tower,
Opp. New Girish Cold Drinks,
Near Vijay Cross Roads,
Navrangpura, Ahmedabad – 380 009
Telephone Number: +91 79 4840 5357
Investors Grievance Id: email@example.com